No Data
No Data
Jinwei Medical (08143): Beijing Bauhinia operations have fully resumed
According to the Zhitong Finance App, Jinwei Medical (08143) issued an announcement. The on-site inspection and inspection of Beijing Bauhinia has been properly completed, and the Health Commission has re-issued a medical institution practice license to Beijing Bauhinia on April 16, 2024. After the medical institution's license was re-issued, the operation of Beijing Bauhinia fully resumed on the date of this announcement.
Jinwei Healthcare (08143): Lin Yaomin was appointed as an independent non-executive director
According to Zhitong Finance App, Jinwei Healthcare (08143) announced that Lin Yaomin has been appointed as an independent non-executive director and a member of the Company Audit Committee, Remuneration Committee, and Nomination and Corporate Governance Committee with effect from April 17, 2024.
Jinwei Medical (08143) Affiliated to Proposes to Lease Hong Kong Properties for Use as Office Space
According to Zhitong Finance App, Jinwei Healthcare (08143) announced that on March 20, 2024, the tenant (Jinwei Innovation Co., Ltd., an indirect wholly-owned subsidiary of the company) and the owner (Huamin Property Co., Ltd.) signed a lease agreement to lease the property. The rental period is 2 years, from February 1, 2024 to January 31, 2026 (including the first and last two days). The total rent is HK$108,800 per month. According to reports, the property is located in Room 3309, 33rd Floor, Shun Tak Centre West Wing, 168-200 Connaught Road Central, Hong Kong, China. The company intends to use the property as a group office property.
GF HEALTHCARE: Interim Report 2023/2024
GF HEALTHCARE: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2023
Jinwei Healthcare (08143): The stock merger will take effect on September 13
According to Zhitong Financial App, Jinwei Healthcare (08143) announced that the GEM Listing Committee of the Stock Exchange has granted approval for the listing and trading of the consolidated shares that have been and will be issued after the share merger takes effect and the consolidated shares to be issued when exercising conversion rights attached to the consolidated preferred shares to be issued. Since all the prerequisites for the share consolidation have been met, the share merger will take effect on September 13, 2023 (Wednesday). Trading of the consolidated shares will commence on September 13, 2023 (Wednesday) at 9:00 a.m. (Hong Kong time) on the Stock Exchange.
No Data